Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.
van Meurs
T
T
Department of Dermatology, VU University Medical Center, 1007 MB Amsterdam, The Netherlands. tvmeurs@hotmail.com
van Doorn
R
R
Kirtschig
G
G
D000279:Administration, Cutaneous; D000634:Aminoquinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D005546:Forehead / Q000473:pathology; D006801:Humans; D018327:Hutchinson's Melanotic Freckle / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D000077271:Imiquimod; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod